Dr. Jaswinder P. Singh

Internal Medicine
2201 Hempstead Tpke, 
East Meadow, NY 
2201 Hempstead Tpke, 
East Meadow, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jaswinder Singh is a primary care provider, practicing in Internal Medicine in East Meadow, New York. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of West Syndrome. His top areas of expertise are Alcoholic Cirrhosis, Sickle Cell Disease, End-Stage Renal Disease (ESRD), Gastrostomy, and Endoscopy.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in NY
Hospital Affiliations
Nassau University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

NASSAU HEALTH CARE CORPORATION
2201 Hempstead Tpke, East Meadow, NY 11554

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: Fruquintinib
Study Phase: Phase 3
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 31, 2024
Intervention Type: Drug, Device
Study Drugs: Gemcitabine, Nab-paclitaxel
Study Phase: Phase 3
An Expanded Access Program of Surufatinib for Patients With Advanced or Metastatic Neuroendocrine Tumors
An Expanded Access Program of Surufatinib for Patients With Advanced or Metastatic Neuroendocrine Tumors
Enrollment Status: No_longer_available
Publish Date: April 12, 2024
Intervention Type: Drug
VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent
VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent
Enrollment Status: Terminated
Publish Date: February 05, 2024
Intervention Type: Drug
Study Drugs: VERU-111, Enzalutamide, Abiraterone, Darolutamide and Apalutamide
Study Phase: Phase 3
A Phase II Study of the Combination of LY3023414 and Necitumumab After First-Line Chemotherapy for Metastatic Squamous Non-small Cell Carcinoma of the Lung
A Phase II Study of the Combination of LY3023414 and Necitumumab After First-Line Chemotherapy for Metastatic Squamous Non-small Cell Carcinoma of the Lung
Enrollment Status: Terminated
Publish Date: December 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
An Adaptive, Open-Label, Randomized Phase 2 Study of Abemaciclib as a Monotherapy and in Combination With Other Agents Versus Choice of Standard of Care (Gemcitabine or Capecitabine) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma
An Adaptive, Open-Label, Randomized Phase 2 Study of Abemaciclib as a Monotherapy and in Combination With Other Agents Versus Choice of Standard of Care (Gemcitabine or Capecitabine) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma
Enrollment Status: Completed
Publish Date: November 20, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer Pain
A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer Pain
Enrollment Status: Withdrawn
Publish Date: February 15, 2019
Intervention Type: Other, Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

15 Total Publications

Suspected Emphysematous Cellulitis of the Face Secondary to Untreated Nondisplaced Angle of the Mandible Fracture: A Case Report.
Suspected Emphysematous Cellulitis of the Face Secondary to Untreated Nondisplaced Angle of the Mandible Fracture: A Case Report.
Journal: Case reports in dentistry
Published: December 09, 2023
Similar Doctors
Advanced in West Syndrome
Dr. Marco Tartaglia
Internal Medicine
Advanced in West Syndrome
Dr. Marco Tartaglia
Internal Medicine
20 Watsessing Ave, 
Bloomfield, NJ 
 (33.1 miles away)
973-364-0888
Languages Spoken:
English

Marco Tartaglia is a primary care provider, practicing in Internal Medicine in Bloomfield, New Jersey. Dr. Tartaglia is rated as an Elite provider by MediFind in the treatment of West Syndrome. His top areas of expertise are RASopathies, Noonan Syndrome, Cardiomyopathic Lentiginosis, and Rommen Mueller Sybert Syndrome.

Experienced in West Syndrome
Dr. Robert A. Roche-Barnett
Internal Medicine
Experienced in West Syndrome
Dr. Robert A. Roche-Barnett
Internal Medicine

North Shore Hematology Oncology Associates PC

48 Route 25a, 
Smithtown, NY 
 (21.3 miles away)
631-751-3000
Languages Spoken:
English
See accepted insurances

Robert Roche-Barnett is a primary care provider, practicing in Internal Medicine in Smithtown, New York. Dr. Roche-Barnett is rated as an Advanced provider by MediFind in the treatment of West Syndrome. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, Tracheitis, and Gastrostomy.

Advanced in West Syndrome
Dr. Sumaiya Iqbal
Internal Medicine
Advanced in West Syndrome
Dr. Sumaiya Iqbal
Internal Medicine

HMH - Primary Care - Piscataway

1080 Stelton Road, 
Piscataway, NJ 
 (47.0 miles away)
848-230-6810
Experience:
10+ years
Languages Spoken:
English
See accepted insurances

Sumaiya Iqbal is a primary care provider, practicing in Internal Medicine in Piscataway, New Jersey. Dr. Iqbal has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of West Syndrome. Her top areas of expertise are West Syndrome, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Athetosis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Singh's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 119 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile